- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01346683
Study on OsseoSpeed™ TX Implants in a Chinese Population
September 11, 2019 updated by: Dentsply Sirona Implants and Consumables
An Open, Prospective, Multi-center Study to Evaluate the OsseoSpeed™ TX Implant With an Early Loading Protocol in Patients With Tooth Loss in the Posterior Mandible. A 3-years Follow-up Study.
To investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible up to 3 years after loading.
Hypothesis: Early loading of the posterior mandible is a safe and predictable procedure.
Study Overview
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100081
- Department of Prosthodontics, School of Stomatology, Beijing University
-
Guangzhou, China, 510055
- Department of Prosthodontics & Dental Materials, Guanghua School of Stomatology, Sun Yat-Sen University
-
Shanghai, China, 200011
- Department of Prosthodontics, College of Stomatology, Shanghai Jiao Tong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- Provision of informed consent
- Aged 20-75 years at enrolment
- History of edentulism in the posterior mandible, Kennedy classes I or II, of at least four months. Last natural tooth in function is canine or first bicuspid.
- Neighboring tooth to the planned bridge must have natural root.
- Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge.
- Deemed by the investigator to have adequate bone height and a bone width of minimum 5.5 mm.
- Deemed by the investigator as likely to present an initially stable implant situation
Exclusion criteria:
- Unlikely to be able to comply with study procedures, as judged by the investigator
- Earlier graft procedures in the study area
- Current need for pre-surgical bone or soft tissue augmentation in the planned implant area.
- Uncontrolled pathologic processes in the oral cavity
- Known or suspected current malignancy
- History of radiation therapy in the head and neck region
- History of chemotherapy within 5 years prior to surgery
- Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
- Uncontrolled diabetes mellitus
- Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
- Smoking more than 10 cigarettes/day
- Present alcohol and/or drug abuse
- Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
- Previous enrolment in the present study.
- Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months.
- Subjects that are unable to give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: OsseoSpeed TX
OsseoSpeed TX implants of lengths 8-17 mm
|
OsseoSpeed TX implants of lengths 8-17 mm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Marginal Bone Level Alteration
Time Frame: Evaluated 3 years after implant loading
|
Marginal Bone Level determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.
Marginal Bone Level expressed in millimeters at the 3 year follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).
|
Evaluated 3 years after implant loading
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implant Survival
Time Frame: From implant placement to the follow-up 36 months after loading.
|
Implant survival rate evaluated clinically and radiographically.
|
From implant placement to the follow-up 36 months after loading.
|
Implant Stability
Time Frame: Measured from loading of implants to the follow-up 36 months after loading.
|
Implant stability evaluated clinically/manually (recorded as stable yes/no)
|
Measured from loading of implants to the follow-up 36 months after loading.
|
Soft Tissue Status (PPD).
Time Frame: Measured from loading of implants to the follow-up 36 months after loading.
|
Soft tissue status measured by assessment of probing pocket depth (PPD). PPD was measured at 4 different surfaces (mesial, distal, buccal and lingual) and change compared to baseline (loading) was analyzed. A negative value = increased pocket depth. |
Measured from loading of implants to the follow-up 36 months after loading.
|
Soft Tissue Status (BoP)
Time Frame: Measured from loading of implants to the follow-up 36 months after loading.
|
Soft tissue status measured by assessment of bleeding on probing (BoP).
|
Measured from loading of implants to the follow-up 36 months after loading.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yongsheng Zhou, Prof, Department of Prosthodontics, School of Stomatology, Beijing University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2011
Primary Completion (ACTUAL)
March 1, 2016
Study Completion (ACTUAL)
March 1, 2016
Study Registration Dates
First Submitted
May 2, 2011
First Submitted That Met QC Criteria
May 2, 2011
First Posted (ESTIMATE)
May 3, 2011
Study Record Updates
Last Update Posted (ACTUAL)
September 27, 2019
Last Update Submitted That Met QC Criteria
September 11, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHN-0002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partially Edentulous Jaw
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
University of Alabama at BirminghamZimmer DentalCompleted
-
Institut Straumann AGCompletedJaw, Edentulous, Partially | Jaw, EdentulousBelgium
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyUnited States, Germany
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompleted
-
NeodentActive, not recruiting
-
University of MichiganTerminatedJaw, Edentulous, PartiallyUnited States
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyUnited States, Germany
Clinical Trials on OsseoSpeed TX
-
Dentsply Sirona ImplantsCompletedPartial Edentulism in the Maxilla or in the MandibleUnited States, Belgium, Germany, Italy
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Dentsply Sirona Implants and ConsumablesCompletedPartial Edentulism | Edentulism NosSweden
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyDenmark, Germany, Italy, Spain, Sweden, United Kingdom
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Dentsply Sirona Implants and ConsumablesCompletedOsteopenia | Jaw, Edentulous, Partially | Postmenopausal OsteoporosisBelgium, Germany, Sweden
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyUnited States, Germany